Asthma-related lung function, sleep quality, and sleep duration in urban children

Daphne Koinis-Mitchell1, Sheryl J Kopel1, Ronald Seifer1

  • 1Bradley/Hasbro Children's Research Center, Providence, RI; Alpert Medical School, Brown University, Providence, RI,; Hasbro Children's Hospital/Rhode Island Hospital, Providence, RI.

Sleep Health
|May 21, 2017
PubMed

Insights

Worsening asthma lung function is linked to poor sleep quality in children. Ethnic differences exist, with urban minority children potentially facing higher risks for sleep issues.

Area of Science:

  • Pediatric Pulmonology
  • Sleep Medicine
  • Environmental Health

Background:

  • Persistent asthma affects urban children, potentially impacting sleep quality.
  • Asthma management often focuses on daytime symptoms, with less attention to nocturnal lung function and sleep interactions.
  • Understanding the interplay between lung function and sleep is crucial for comprehensive asthma care in children.

Purpose of the Study:

  • To investigate the association between objectively measured asthma-related lung function changes during sleep and sleep quality/duration in urban children with persistent asthma.
  • To examine relationships between morning/evening lung function and adjacent night sleep quality/duration.
  • To determine if these associations differ across ethnic groups.

Main Methods:

  • A cross-sectional, multimethod study involving 216 urban children (ages 7-9) of diverse ethnic backgrounds.
  • Home-based objective measurements of lung function (spirometry) and sleep (actigraphy) over 4 weeks.
  • Clinic assessments and diary-based questionnaires for asthma symptoms and sleep patterns.

Main Results:

  • Worsening asthma-related lung function correlated with poorer sleep quality in the overall sample.
  • Better nighttime lung function was associated with more optimal sleep efficiency.
  • Significant ethnic group differences were observed in the associations between lung function and sleep quality.

Conclusions:

  • Urban minority children with asthma may experience a heightened risk of poorer sleep quality.
  • The timing of lung function decline is a critical factor in addressing both asthma outcomes and sleep quality.
  • Interventions should consider ethnic-specific approaches to improve sleep and asthma control in pediatric populations.
Abstract

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.4K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.0K